The Board of Directors of Alembic Pharmaceuticals Limited at its meeting on July 28, 2014, approved the designation of Mr. R. K. Baheti, Director of-Finance and Company Secretary of the company as Director - Finance and Chief Financial Officer of the company effective July 28, 2014 and designation of Mr. Ajay Kumar Desai, Associate Vice President-Finance of the company as Associate Vice President-Finance and Company Secretary and Compliance Officer of the company effective July 28, 2014.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
922 INR | -0.12% | -2.82% | +21.30% |
May. 30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
May. 09 | Transcript : Alembic Pharmaceuticals Limited, Q4 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.30% | 2.17B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- APLLTD Stock
- News Alembic Pharmaceuticals Limited
- Alembic Pharmaceuticals Limited Announces Management Changes